Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Cancer Management and Research|December 12, 2019
Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In ChinaRuxu You, Jinyu Liu, David Bin-Chia Wu, et al.BMC Urology|April 28, 2023
A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in JapanRaf De Moor, Yosuke Koroki, David Bin-Chia Wu, et al.Frontiers in Pharmacology|May 20, 2020
Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in ChinaRuxu You, Yu Zhang, David Bin-Chia Wu, et al.Urology|September 19, 2013
Does simultaneous inversion during extracorporeal shock wave lithotripsy improve stone clearance: a long-term, prospective, single-blind, randomized controlled studyWing Seng Leong, Men Long Liong, Yee Vonne Liong, et al.Value in Health Regional Issues|May 15, 2019
Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic ReviewNoor Razilah Abdul Rafar, Yet Hoi Hong, David Bin-Chia Wu, et al.Journal of Gastroenterology and Hepatology|December 7, 2011
Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong KongKenneth K C Lee, David Bin Chia Wu, Pui Yu Chow, et al.Neuropsychiatric Disease and Treatment|March 4, 2016
Global economic burden of schizophrenia: a systematic reviewHuey Yi Chong, Siew Li Teoh, David Bin-Chia Wu, et al.Psychiatry Research|January 23, 2026
Clinical remission, functional recovery, and employment in early-phase schizophrenia treated with paliperidone palmitate: An 18-month longitudinal Asia-Pacific studyChien-Heng Lin, Chih-Lin Chiang, Dae Young Yu, et al.Thrombosis Research|December 3, 2014
Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in ThailandHuey Yi Chong, Surasak Saokaew, Kuntika Dumrongprat, et al.BMC Cancer|March 29, 2018
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspectivePing-Tee Tan, Mohamed Ismail Abdul Aziz, Fiona Pearce, et al.Pageof 7